Spiral
metadata only
CC BY 4.0
Mycophenolate and azathioprine in fibrotic interstitial lung disease
Rationale Immunosuppression is routinely used for non–idiopathic pulmonary fibrosis (IPF) interstitial lung diseases (ILDs), despite limited trial evidence and unclear impact on long-term outcomes. Objectives To evaluate whether mycophenolate or azathioprine improves 3-year transplant-free survival
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Prospective Evaluation of Biomarker Profiles in Idiopathic Pulmonary Fibrosis#1243042
- Microparticles and Bronchiolitis Obliterans Syndrome#1087216
- Defining the Molecular and Radiologic Phenotype of Progressive RA Interstitial Lung Disease#828183
- Unlocking the potential of radiomics in identifying fibrosing and inflammatory patterns in interstitial lung disease#445717
- Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate#1228935
Record · ID 1368404
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive